Policy, Organisation and Incentives in Health Systems
Health system policies should incentivise high-quality health care in areas of highest need at the lowest feasible cost. Our aim is to expand our understanding of policies that result in healthier populations and achieve sustainability while being responsive to patients’ needs.
Question of Balance: the Benefits and Risks of Pharmaceutical Innovation
1 May 1980
Since this monograph was completed, two new stories concerning the safety of medicines have been featured prominently in the British press. The first has been on…
Perinatal Mortality in Britain – A Question of Class
1 December 1979
This OHE Briefing illustrates some of the difficulties inherent in making accurate international and international comparisons with regard to perinatal mortality, the most sensitive widely collected…
Immunisation for Everyone – The Polio Experience
1 September 1979
In the richer nations of Europe and North America the gaining of control over the common infectious illnesses was a long, gradual process. It was initiated…
Scarce Resources in Health Care
2 January 1979
Over the past few years serious efforts have been made in Britain and elsewhere to achieve a more rational distribution of health care resources. It has…
Cost of the NHS
1 October 1978
In 1978 the cost of the National Health Service in the United Kingdom will rise, to an estimated record level of £8,000 million. Even when adjusted…
Health Care Research Expenditure
1 June 1978
In the financial year 1976-77 over £220 million was spent on health care research in the United Kingdom. Taking account of recent expenditure growth and making…
Sources of Information for Prescribing Doctors in Britain
9 January 1977
The information which pharmaceutical manufacturers provide for prescribing doctors – in the form of sales promotion and advertising – has been the subject of considerable and…
The Reorganised NHS
1 March 1977
This study of the reorganised National Health Service is divided into two papers. The first describes the new structure and the management concepts on which it…
Brand Names in Prescribing
1 September 1976
To present a balanced view of the brand name/generic controversy and the associated field of bioavailability. Many have discussed these problems; scientists, politicians, industrialists, legislators, hospital…